CTMX vs MSFT · rev $11.7M vs P/E 39, rev $331.84B
CytomX Therapeutics Inc (CTMX) versus Microsoft Corporation (MSFT) — a side-by-side from cached financials, not a winner call.
CytomX Therapeutics Inc (CTMX) is a biotechnology company listed on US.
Microsoft Corporation (MSFT) is a software - infrastructure company listed on US. It is led by Satya Nadella.
Latest reported CTMX revenue for 2026-06-30 was $11.7M. Net income was -$38.9M. Revenue was up 13.8% from 2026-03-31 to 2026-06-30. CTMX currently screens at market cap $653.1M.
Latest reported MSFT revenue for 2026-06-30 was $331.84B. Net income was $133.75B. MSFT currently screens at market cap $3.71T and trailing P/E 38.6.
CTMX currently screens at market cap $653.1M. MSFT currently screens at market cap $3.71T and trailing P/E 38.6.
Not investment advice. Open the CTMX and MSFT stock pages for the full models.
Not investment advice.